Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Netherlands Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20035
20047
20057
200612
20074
200810
20098
201011
20113
20123
20132
20145
20154
20173
20182
20192
20202
20211
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Terminated8
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S22
Boehringer Ingelheim15
AstraZeneca14
Sanofi14
Takeda8
GlaxoSmithKline4
Eli Lilly and Company3
Medical Research Foundation, The Netherlands3
Bayer2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2108
Diabetes Mellitus39
Dyslipidemias10
Glucose Metabolism Disorders9
Cardiovascular Diseases5
Hypertension5
Diabetes Mellitus, Type 14
Diabetic Nephropathies4
Kidney Diseases4
Coronary Artery Disease3

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.